BaladoCritique : Club de lecture médical est une baladodiffusion (podcast) francophone mensuelle qui analyse et commente les études récentes d’impact majeur en médecine interne. Ces articles sont sélectionnés par un groupe d’experts en lecture critique de l’Université de Sherbrooke et de l’Université Laval en fonction du potentiel de changement de pratique en médecine familiale/médecine interne. Nous espérons que cet outil facilitera le transfert de nouvelles connaissances médicales aux professionnels de la santé et améliorera ainsi votre pratique médicale.
Épisode 68: Durée d’antibiothérapie pour les bactériémies (étude BALANCE)
Diffusé le 21 janvier 2025
Dans cette 68e baladodiffusion, les Drs Luc Lanthier et Alex Carignan discutent de durée d’antibiothérapie pour les bactériémies, en plus de réviser la littérature médicale de novembre et décembre 2024.
Quiz clinique (2 min 15), présentation principale (2 min 49), critique (20 min 19), retour sur le cas clinique (26 min 26), autres articles (28 min 25), réponse au quiz clinique (33 min 18)
BALANCE Investigators, for the Canadian Critical Care Trials Group, the Association of Medical Microbiology and Infectious Disease Canada Clinical Research Network, the Australian and New Zealand Intensive Care Society Clinical Trials Group, and the Australasian Society for Infectious Diseases Clinical Research Network; Daneman N, Rishu A, Pinto R, Rogers BA, Shehabi Y, Parke R, et al. Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections. N Engl J Med. 2024 Nov 20. doi: 10.1056/NEJMoa2404991. PubMed PMID: 39565030.
Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, et al; Bacteremia Duration Study Group. Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial. Clin Infect Dis. 2019;69(7):1091-1098. PubMed PMID: 30535100.
von Dach E, Albrich WC, Brunel AS, Prendki V, Cuvelier C, Flury D, et al. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA. 2020;323(21):2160-2169. PubMed PMID: 32484534.
Molina J, Montero-Mateos E, Praena-Segovia J, León-Jiménez E, Natera C, López-Cortés LE, et al; SHORTEN trial team. Seven-versus 14-day course of antibiotics for the treatment of bloodstream infections by Enterobacterales: a randomized, controlled trial. Clin Microbiol Infect. 2022;28(4):550-557. PubMed PMID: 34508886.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, et al. Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial. Lancet. 2024:404(10464);1731-41. PubMed PMID: 39491870.
Anker SD, Friede T, von Bardeleben RS, Butler J, Khan MS, Diek M, et al. Transcatheter Valve Repair in Heart Failure with Moderate to Severe Mitral Regurgitation. N Engl J Med. 2024;391(19):1799-809. PubMed PMID: 39216092.
Cho MS, Kang DY, Ahn JM, Yun SC, Oh YS, Lee CH, et al. Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease. N Engl J Med. 2024;391(22):2075-86. PubMed PMID: 39225258.
Kang DY, Lee SH, Lee SW, Lee CH, Kim C, Jang JY, et al. Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery. J Am Coll Cardiol. 2024;84(24):2380-9. PubMed PMID: 39217573.
Tan J, Zhu R, Li Y, Wang L, Liao S, Cheng L, et al. Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial. JAMA Intern Med. 2024;184(12):1443-7. PubMed PMID: 39466236.
Hobbs FDR, McManus RJ, Taylor CJ, Jones NR, Rahman JK, Wolstenholme J, et al. Low-dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: a randomized controlled trial. Nat Med. 2024;30(12):3634-45. PubMed PMID: 39349629.
Diabetes Canada Clinical Practice Guidelines Expert Working G, Shah BR, Bajaj HS, Butalia S, Dasgupta K, Eurich DT, et al. Pharmacologic Glycemic Management of Type 2 Diabetes in Adults-2024 Update. Can J Diabetes. 2024;48(7):415-24. PubMed PMID: 39550176.
Thompson A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;150(19):e351-e442. PubMed PMID: 39316661.
Yakovenko I, Mukaneza Y, Germe K, Belliveau J, Fraleigh R, Bach P, et al. Management of opioid use disorder: 2024 update to the national clinical practice guideline. CMAJ. 2024;196(38):E1280-E90. PubMed PMID: 39532476.
Singh S, Loftus EV, Jr., Limketkai BN, Haydek JP, Agrawal M, Scott FI, et al. AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2024;167(7):1307-43. PubMed PMID: 39572132.
Bushnell C, Kernan WN, Sharrief AZ, Chaturvedi S, Cole JW, Cornwell WK, 3rd, et al. 2024 Guideline for the Primary Prevention of Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2024;55(12):e344-e424. PubMed PMID: 39429201.
Sico JJ, Antonovich NM, Ballard-Hernandez J, Buelt AC, Grinberg AS, Macedo FJ, et al. 2023 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for the Management of Headache. Ann Intern Med. 2024;177(12):1675-94. PubMed PMID: 39467289.
Les BaladoCritiques sont offertes en collaboration avec le Centre de formation continue (CFC) de la Faculté de Médecine et des sciences de la santé de l'Université de Sherbrooke. Pour connaître toutes les offres de formation du CFC, cliquez ici.
